Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 801 results for "tyrosine"

Ten Years of Targeted Treatment in Lung Cancer
Medical Grapevine

35 images for tyrosine

Sexual Development, 1 week ago
Scientific Computing, 2 weeks ago
SPi World News, 4 weeks ago
AllAboutFeed.net, 1 month ago
MyScience, 1 month ago
Asian Scientist, 1 month ago
Drug Discovery and Development, 1 month ago
International Journal of Laboratory Hematology, 2 months ago
Chemotherapy Advisor, 2 months ago
Huffington Post UK, 1 month ago

New Optogenetic Tool for Controlling Neuronal Signaling by Blue Light

Successfully inducing cell differentiation by light through the use of light-inducible receptor tyrosine kinases Institute for Basic Science (IBS), the main organization of the International Science and Business Belt project in South Korea, has ...
 Medical Design Technology2 weeks ago Inducing cell differentiation by light through the use of light-inducible receptor tyrosine kinases  Medical News Today2 weeks ago

Synthesis of Adhesive Peptides Similar to Those Found in Blue Mussel (Mytilus edulis) Using Papain and Tyrosinase

The blue mussel (Mytilus edulis) foot protein 5 (Mefp-5) is an adhesive protein that is mainly composed of glycine, l-lysine, and 3,4-dihydroxy-l-phenylalanine (DOPA). Thousands of adhesive pads have been analyzed in previous studies, whereby it has ...
 Biomacromolecules1 hour ago

CRIPTO1 role in TKI resistance elucidated

Overexpression of CRIPTO1 may explain intrinsic tyrosine kinase inhibitor (TKI) resistance in around 10% of patients with non-small-cell lung cancer (NSCLC) and endothelial growth factor receptor (EGFR) mutations, research indicates. CRIPTO1 ...
 News-Medical.Net2 hours ago Discontinuation of the tyrosine kinase inhibitor sunitinib in patients with metastatic renal cell carcinoma: A case series - Abstract  UroToday6 days ago Sequential tyrosine kinase inhibitors (TKIs) in metastatic renal cell carcinoma: results from a large cohort of patients - Abstract  UroToday2 weeks ago Survival of patients undergoing cytoreductive surgery for metastatic renal cell carcinoma in the targeted-therapy era - Abstract  UroToday2 weeks ago

Gallium-68-Labeled Affibody Molecule for PET Imaging of PDGFRβ Expression in Vivo

Platelet-derived growth factor receptor β (PDGFRβ) is a transmembrane tyrosine kinase receptor involved, for example, in angiogenesis. Overexpression and excessive signaling of PDGFRβ has been observed in multiple malignant tumors and fibrotic ...
 Molecular Pharmaceutics4 hours ago

Yes Tyrosine Kinase Inhibitors -Pipeline Insights, 2014

Naperville, IL -- (SBWIRE) -- 07/23/2014 -- Reportstack, provider of premium market research reports announces the addition of market report to its offering DelveInsights,Yes Tyrosine Kinase Inhibitors-Pipeline Insights, 2014, report provides ...
 Town Hall7 hours ago Wee1 Tyrosine Kinase Inhibitors -Pipeline Insights, 2014  Wall Street Business Network7 hours ago
[x]  
Sexual Development

B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

Activation of the B cell receptor involves phosphorylation of the cytoplasmic immunoreceptor tyrosine-based activation motifs (ITAMs) present in Ig alpha and beta. This leads to activation of several non-receptor tyrosine kinases including those of ...
 MarketResearch.com1 day ago Tyrosine Kinase Inhibitors in EGFR-Mutated Large-Cell Neuroendocrine Carcinoma of the Lung A Case Report  Sexual Development1 week ago Modulators of the Actin Cytoskeleton for the Treatment of Cancer Drug Pipeline Update 2014  MarketResearch.com15 hours ago IL-9 Signaling Pathway in Oncology Drug Pipeline Update 2014  MarketResearch.com18 hours ago
[x]  

Ignyta launches clinical trials for metastatic cancer drug

US oncology biotech firm Ignyta Inc (NASDAQ:RXDX) said Monday it had begun a Phase I/II study of its oral tyrosine kinase inhibitor, RXDX-101, for the treatment of adults with locally advanced or metastatic cancer confirmed to be positive for ...
 MedCity News2 days ago Targeted therapy for renal cell carcinoma: The next lap - Abstract  UroToday1 day ago Ignyta Announces Initiation of STARTRK-1 Global Phase I/II Clinical Trial of RXDX-101  EON: Enhanced Online News2 days ago Ignyta Inc announces initiation of STARTRK-1 global phase I/II clinical trial of RXDX-101  Reuters UK2 days ago
[x]  

A phase I study of cabozantinib (XL184) in patients with renal cell cancer - Abstract

BACKGROUND: Cabozantinib targets tyrosine kinases including the hepatocyte growth factor receptor (MET) and vascular endothelial growth factor (VEGF) receptor 2, which are important drug targets in renal cell carcinoma (RCC). Renal Cancer ...
 UroToday2 days ago

Ratiometric fluorescent chemosensor based on Tyrosine derivatives for monitoring mercury ions in aqueous solutions

We welcome your comments for improvement of this site and our services. Comments Email ID Security Details ...
 RSC6 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less